Two former Theranos directors said they didn’t follow up on public allegations that the blood-testing firm was relying on standard technology rather than its much-hyped proprietary device for most tests, according to newly released court documents.
from WSJ.com: US Business http://ift.tt/2riN8KJ
via IFTTT
No comments:
Post a Comment